Skip to main content

Randall Kenneth Edward's Form 4 filing

TC BioPharm (Holdings) plc (TCBP) · filed Jan 11, 2023

Accession no.
0001920179-23-000002
Filed
Jan 11, 2023
Trade date
Nov 30, 2022
Filing delay
42 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market purchases total $350.0K. It was filed 42 days after the trade, past the 2-business-day deadline.

This filing was later replaced by the amendment 0001920179-23-000004 (Jan 11, 2023). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Randall Kenneth EdwardCIK 000192992610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 30, 2022Ordinary Shares [ADS]PPurchaseAcquired+70,000$5.00+$350,000382,963Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 30, 2022Ordinary SharesPPurchaseAcquired+70,000$0.00F1$070,000Indirect
Nov 30, 2022Ordinary SharesPPurchaseAcquired+70,000$0.00F2$070,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Series A Warrants were issued as part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of %5.00.

Referenced by the price of 1 transaction in Table II.

F2

Series B Warrants were issued as part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of %5.00.

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)